Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

Levoleucovorin calcium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for levoleucovorin calcium and what is the scope of levoleucovorin calcium patent protection?

Levoleucovorin calcium
is the generic ingredient in two branded drugs marketed by Actavis Llc, Spectrum Pharms, Amneal Pharms Co, West-ward Pharms Int, Sandoz Inc, and Mylan Teoranta, and is included in seven NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Levoleucovorin calcium has twenty-one patent family members in nine countries.

There is one drug master file entry for levoleucovorin calcium. Six suppliers are listed for this compound.

Summary for Generic Name: levoleucovorin calcium

Drug Master File Entries: see list1
Suppliers / Packagers: see list6
Bulk Api Vendors: see list25
Clinical Trials: see list725
Patent Applications: see list3,666
Drug Prices:see low prices
DailyMed Link:levoleucovorin calcium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Spectrum Pharms
levoleucovorin calcium
SOLUTION;IV (INFUSION)020140-003Apr 29, 2011DISCNYesNo► Subscribe► Subscribe
Spectrum Pharms
levoleucovorin calcium
POWDER;IV (INFUSION)020140-001Mar 7, 2008APRXYesYes► Subscribe► Subscribe
Spectrum Pharms
levoleucovorin calcium
SOLUTION;IV (INFUSION)020140-003Apr 29, 2011DISCNYesNo6,500,829► SubscribeYY ► Subscribe
Actavis Llc
levoleucovorin calcium
POWDER;IV (INFUSION)206516-001Feb 13, 2017APRXNoNo► Subscribe► Subscribe
Mylan Teoranta
levoleucovorin calcium
SOLUTION;IV (INFUSION)203576-001Oct 20, 2015APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus